2,3-Diethylthiirane | 30465-45-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 硫杂环丙烷
• 英文名称: 2,3-Diethylthiirane
• CAS: 30465-45-3
• 化学式: C₆H₁₂S
• 分子量: 116.23
• InChiKey: BIQQKNMQSYWGFU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  7
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  25.3
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
  申请人：Farmer J. Luc

  公开号：US20080045480A1

  公开（公告）日：2008-02-21

  The present invention relates to peptidomimetic compounds that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The invention further relates to compositions comprising these compounds either for ex vivo use or for administration to a patient suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a patient by administering a composition comprising a compound of this invention.

  本发明涉及一种抑制丝氨酸蛋白酶活性的肽类类似物化合物，特别是抑制丙型肝炎病毒NS3-NS4A蛋白酶的活性。因此，它们通过干扰丙型肝炎病毒的生命周期来发挥作用，并且也可用作抗病毒剂。本发明还涉及包含这些化合物的组合物，无论是用于体外使用还是用于治疗患有HCV感染的患者的给药。本发明还涉及通过给予含有本发明化合物的组合物来治疗患有HCV感染的患者的方法。
• INHIBITORS OF SERINE PROTEASES, PARTICULARLY HCV NS3-NS4A PROTEASE
  申请人：Cottrell Kevin M.

  公开号：US20100330109A1

  公开（公告）日：2010-12-30

  The present invention relates to compounds of formula I: or a pharmaceutically acceptable salt or mixtures thereof that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The invention further relates to compositions comprising these compounds either for ex vivo use or for administration to a patient suffering from HCV infection and to processes for preparing the compounds. The invention also relates to methods of treating an HCV infection in a patient by administering a composition comprising a compound of this invention. The invention further relates to processes for preparing these compounds.

  本发明涉及公式I的化合物，或其药学上可接受的盐或混合物，其能够抑制丝氨酸蛋白酶活性，特别是丙型肝炎病毒NS3-NS4A蛋白酶的活性。因此，它们通过干扰丙型肝炎病毒的生命周期来发挥作用，并且也可用作抗病毒药物。本发明进一步涉及包含这些化合物的组合物，无论是用于体外使用还是用于治疗患有HCV感染的患者的给药，以及制备这些化合物的过程。本发明还涉及通过给予本发明化合物组成的组合物治疗患者的HCV感染的方法。本发明还涉及制备这些化合物的过程。
• Process for producing modified polyaminoamides and their use in epoxy resin curing agents
  申请人：NIPPON SHOKUBAI CO., LTD.

  公开号：EP0647670A1

  公开（公告）日：1995-04-12

  A process for producing a modified polyaminoamide with markedly increased reactivity as an epoxy resin curing agent is disclosed. The process comprises introducing amino groups and mercapto groups into a polyaminoamide by using an aziridine compound and a thiirane compound. The modified polyaminoamide is capable of curing an epoxy resin at a low temperature and at a high rate to provide a cured epoxy resin excellent in anticorrosion and chemical resistance.

  本发明公开了一种生产改性聚氨基酰胺的工艺，这种改性聚氨基酰胺作为环氧树脂固化剂的反应活性明显提高。该工艺包括使用氮丙啶化合物和硫环化合物在聚氨基酰胺中引入氨基和巯基。改性后的聚氨基酰胺能够以较高的速率低温固化环氧树脂，从而提供防腐性和耐化学性极佳的固化环氧树脂。
• COMPOSITION AND POLYMER
  申请人：Asahi Kasei Kabushiki Kaisha

  公开号：EP2735581B1

  公开（公告）日：2021-07-14
• Composition and Polymer
  申请人：Nakamura Akitake

  公开号：US20140121293A1

  公开（公告）日：2014-05-01

  Disclosed is a composition comprising (A) at least one compound selected from the group consisting of an ether compound having two or more ether groups, a trivalent phosphorus compound, and a ketone compound, (B) a boron trihalide, and (C) an episulfide compound.